Possible central effect of dantrolene sodium in neuroleptic malignant syndrome.
D001921:Brain / Q000187:drug effects*; D003620:Dantrolene / Q000627:therapeutic use*; D005260:Female; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000188:drug therapy*
D003620:Dantrolene; D006220:Haloperidol